(Q33501839)
Statements
1 reference
A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor (English)
1 reference
Verschraegen CF
1 reference
Natelson EA
1 reference
Giovanella BC
1 reference
Kavanagh JJ
1 reference
Kudelka AP
1 reference
Freedman RS
1 reference
Edwards CL
1 reference
Ende K
1 reference
Stehlin JS
1 reference
1 reference